D
Dania O. Govea-Alonso
Researcher at Universidad Autónoma de San Luis Potosí
Publications - 34
Citations - 697
Dania O. Govea-Alonso is an academic researcher from Universidad Autónoma de San Luis Potosí. The author has contributed to research in topics: Antigen & Epitope. The author has an hindex of 13, co-authored 27 publications receiving 552 citations.
Papers
More filters
Journal ArticleDOI
An overview of bioinformatics tools for epitope prediction
TL;DR: A compilation of useful bioinformatics tools for vaccine development is presented in this paper, where the most advantageous online immunological software and searchable tools are presented, in order to facilitate the design and development of vaccines.
Journal ArticleDOI
A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice
Néstor Rubio-Infante,Dania O. Govea-Alonso,Ángel G. Alpuche-Solís,Ana Lilia García-Hernández,Ruth Elena Soria-Guerra,L. M. Teresita Paz-Maldonado,Damaris Ilhuicatzi-Alvarado,Javier T. Varona-Santos,Leticia Verdín-Terán,Schuyler S. Korban,Leticia Moreno-Fierros,Sergio Rosales-Mendoza +11 more
TL;DR: In this article, a synthetic gene encoding a C4V3 recombinant protein, known to induce systemic and mucosal immune responses in mammalian systems, has been introduced into tobacco chloroplasts to yield high levels of expression.
Journal ArticleDOI
Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine
Ruth Elena Soria-Guerra,Jocelín Itzel Ramírez-Alonso,Alejandro Ibáñez-Salazar,Dania O. Govea-Alonso,Luz María Teresita Paz-Maldonado,Bernardo Bañuelos-Hernández,Schuyler S. Korban,Sergio Rosales-Mendoza +7 more
TL;DR: A chimeric protein targeting Angiotensin II via genetic fusion to a nucleocapsid antigen from Hepatitis B virus, serving as a carrier, is designed, and this candidate immunogen designated as HBcAgII has been expressed in the alga specie Chlamydomonas reinhardtii,serving as an attractive vaccine expression system and delivery host.
Journal ArticleDOI
Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.
Regina Ríos-Huerta,Elizabeth Monreal-Escalante,Dania O. Govea-Alonso,Carlos Angulo,Sergio Rosales-Mendoza +4 more
TL;DR: The LTB-EBOV protein was expressed in plant tissues at levels up to 14.7 µg/g fresh leaf tissue and proven to be immunogenic in BALB/c mice when administered by either subcutaneous or oral routes and IgA and IgG responses were induced following the oral immunization.
Journal ArticleDOI
Developing plant-based vaccines against neglected tropical diseases: Where are we?
Sergio Rosales-Mendoza,Dania O. Govea-Alonso,Elizabeth Monreal-Escalante,Gladis Fragoso,Edda Sciutto +4 more
TL;DR: Efforts conducted by a number of research groups to develop vaccines as a mean to fight rabies, cysticercosis, dengue, and helminthiasis are emphasized, and future perspectives are identified, such as the need to develop vaccination models for more than ten pathologies through a plant-based biotechnological approach.